IDH1 and central nervous system cancer: Moreover, because of lack of the molecular pathology information in our samples, which may cause some statistical bias, such as the prognosis of grade IV patient with IDH mutated is significantly better than that of grade IV patients with IDH wild type, two different subtypes of gliomas may have different prognostic factors affecting OS and PFS, which is an underexplored part of our study.